Form D · Other
RevMedx, Inc.
Wilsonville, OR · CIK 0001668651
Offering snapshot reported Mar 21, 2016 · SEC filing
- Reported sold
- $3.52M Offering amount: $5.52M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 26, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 21, 2016 | Initial | $3,518,377 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-259664
Series A Preferred Stock Offering ($2,518,376.71 of the shares were issued pursuant to the conversion of convertible promissory notes)
Source: Form D, filed Mar 21, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Andrew D. Barofsky | Director, Executive |
| Shari D. Beke | Executive |
| Kenton W. Gregory | Director, Executive |
Issuer details
Industry: Other (See others in industry)
Address:
25999 Sw Canyon Creek Road, Suite C
Wilsonville, OR, 97070
Wilsonville, OR, 97070